Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Bufadienolides originated from toad source and their anti-inflammatory activity

Denglang ZouCollege of Pharmacy, Jinan University, Guangzhou, ChinaQiqi WangCollege of Pharmacy, Jinan University, Guangzhou, ChinaTao ChenNorthwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, ChinaDuocheng SangSchool of Life Science, Qinghai Normal University, Xining, ChinaTingqin YangSchool of Life Science, Qinghai Normal University, Xining, ChinaYuhan WangSchool of Life Science, Qinghai Normal University, Xining, ChinaMengze GaoSchool of Life Science, Qinghai Normal University, Xining, ChinaFangfang HeSchool of Life Science, Qinghai Normal University, Xining, ChinaYulin LiNorthwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, ChinaLiangliang HeCollege of Pharmacy, Jinan University, Guangzhou, ChinaDuojie LongzhuSchool of Life Science, Qinghai Normal University, Xining, China
2022en
ABI

Аннотация

Bufadienolide, an essential member of the C-24 steroid family, is characterized by an α-pyrone positioned at C-17. As the predominantly active constituent in traditional Chinese medicine of Chansu, bufadienolide has been prescribed in the treatment of numerous ailments. It is a specifically potent inhibitor of Na + /K + ATPase with excellent anti-inflammatory activity. However, the severe side effects triggered by unbiased inhibition of the whole-body cells distributed α1-subtype of Na + /K + ATPase, restrict its future applicability. Thus, researchers have paved the road for the structural alteration of desirable bufadienolide derivatives with minimal adverse effects via biotransformation. In this review, we give priority to the present evidence for structural diversity, MS fragmentation principles, anti-inflammatory efficacy, and structure modification of bufadienolides derived from toads to offer a scientific foundation for future in-depth investigations and views.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0